Table: Noile-Immune Biotech - Q1 parent results

Noile-Immune Biotech

14/05/2026 07:43

May 14 (Reuters)- 
             Noile-Immune Biotech Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2026        Mar 31, 2025     Dec 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales                                 2 mln                     
                                     (-17.2 pct)                  
  Operating     loss 202 mln        loss 241 mln                  
  Recurring     loss 152 mln        loss 239 mln                  
  Net           loss 153 mln        loss 240 mln                  
  EPS           loss 3.54 yen       loss 5.55 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Noile-Immune Biotech Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T